Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Autoimmune Pancreatitis

ClinicalTrials.gov lists 27 trials for Autoimmune Pancreatitis or a narrower condition beneath it. Cook Research Incorporated has the most among industry and government lead sponsors, with 1.

MeSH D000081012 Digestive System Diseases C06 C20 C23 Listed by Orphanet as a rare disease
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 1 Phase 1/2 Phase 1/2 1 Phase 2 Phase 2 1 Phase 4 Phase 4 2 Not applicable Not applicable 5 Observational Observational 17 Phase 1 Phase 1 1 Phase 1/2 Phase 1/2 1 Phase 2 Phase 2 1 Phase 4 Phase 4 2 Not applicable Not applicable 5 Observational Observational 17

Trials per phase

27 of the 27 trials are tagged with Autoimmune Pancreatitis itself; the rest are tagged with a narrower condition beneath it.

Get the Autoimmune Pancreatitis report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Autoimmune Pancreatitis trials start? (15)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 4

2002: 1 trials (Observational 1) 2006: 1 trials (Observational 1) 2010: 1 trials (Observational 1) 2012: 1 trials (Phase 1/2 1) 2013: 4 trials (Observational 2, Not applicable 2) 2014: 2 trials (Observational 2) 2016: 3 trials (Not applicable 1, Phase 2 1, Phase 1 1) 2018: 1 trials (Not applicable 1) 2019: 1 trials (Observational 1) 2020: 1 trials (Observational 1) 2021: 2 trials (Observational 2) 2022: 2 trials (Observational 2) 2024: 4 trials (Observational 3, Phase 4 1) 2025: 2 trials (Not applicable 1, Phase 4 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 1
2025 2
2024 4
2022 2
2021 2
2020 1
2019 1
2018 1
2016 3
2014 2

No forecast is made for this condition: it averages 2.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Autoimmune Pancreatitis trials in? (6)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 1
Phase 1/2 1
Phase 2 1
Phase 4 2
Not applicable 5
Observational 17

How many Autoimmune Pancreatitis trials are recruiting? (5)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 1
Recruiting 3
Completed 13
Withdrawn 2
Unknown status 8

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Autoimmune Pancreatitis trials? (1)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Cook Research Incorporated 1

Which drugs are being tested for Autoimmune Pancreatitis? (2)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
RITUXIMAB 2
Inebilizumab 1

Interventions as named in the registry (4)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Glucocorticoids 1
Corticosteroids 1
Glucocorticoids+MMF 1
X: Lenalidomide 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which serious adverse events do Autoimmune Pancreatitis trials report? (6)

Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.

Serious adverse events in this condition's trials
Adverse event Subjects affected Trials
Amaurosis fugax 1 1
Klebsiella urinary tract infection 1 1
Legionella pneumophila pneumonia 1 1
Surgery for pseudotumor 1 1
cold agglutininmediated 1 1

Which publications cover Autoimmune Pancreatitis? (10)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Autoimmune pancreatitis 103919 Exact Orphadata Science knowledge files, Product 1
Autoimmune pancreatitis 103919 Exact Orphanet Rare Disease Ontology (ORDO)

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: prevalence and sub-conditions in mesh.

Browse all condition evidence pages